UpHealth Announces CEO Transition and Organizational Changes

 

Contacts

Investors Relations:
Jay Jennings
Acting Chief Executive Officer
561-270-4417
IR@uphealthinc.com

July 15, 2024

UpHealth Announces CEO Transition and Organizational Changes

DELRAY BEACH, Fla., July. 15, 2024 (PRNewswire) – UpHealth, Inc. (“UpHealth,” the “Company”)
(NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and
services to modernize care delivery and health management, today announced the July 11, 2024
appointment by the Board of Directors of the Company of Jay Jennings, currently the Company’s Chief
Financial Officer, to serve as the Company’s Acting Chief Executive Officer, replacing Martin Beck, who
resigned as Chief Executive Officer effective July 10, 2024. Mr. Beck also resigned from his position as a
Class I director of the Company effective July 10, 2024. On July 11, 2024, the Board determined that it
would not appoint any successor to fill the vacancy created by Mr. Beck’s resignation as a Class I director
at this time.

In addition, the Board promoted Lisa Fluxman to President of TTC Healthcare, Inc., and re-affirmed the
position of Jeremy Livianu as the Chief Legal Officer and Secretary of UpHealth, Inc.
“The Board of UpHealth wants to thank Martin Beck for his service as the CEO of the Company during
the last year and wish him much luck in his future endeavors. The Board has confidence that the newly
assigned leadership team of Jay, Lisa, and Jeremy will work diligently and closely with the Board to steer
the Company through the continuous successful restructuring activities and resolutions of all legal
challenges that the Company has been confronting for the last few years,” said Dr. Avi Katz, Chairman of
the Board of UpHealth and all its subsidiaries.”

 

Scroll to Top

UpHealth Inc.UPH

$2.355-0.105-4.27%
2.3511002.363000
December 15, 2021 1:55 PMESTDecember 15, 2021Volume: 541,047
USDNew York Stock ExchangeDelayed Price